Inactive Instrument

Corium International Inc Share Price

Equities

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease	27/01/20	GL
Corium Appoints Perry Sternberg as Chief Executive Officer	02/04/19	GL
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025	17/12/18	GL
Corium International : RM LAW Announces Investigation of Corium International, Inc.	15/10/18	PR
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares	11/10/18	GL

Director	Title	Age	Since
Perry Sternberg CEO	Chief Executive Officer	55	31/03/19
John Miller DFI	Director of Finance/CFO	-	-
Steven N. Gersten CMP	Compliance Officer	-	-

Manager	Title	Age	Since
Travis Wilson BRD	Director/Board Member	-	26/11/18
Sophie Kornowski-Bonnet CHM	Chairman	61	26/11/18
David S. Moore BRD	Director/Board Member	50	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ELI LILLY AND COMPANY	-1.21%	+2.33%	+54.24%	+288.18%	832B
NOVO NORDISK A/S	+0.47%	+4.20%	+36.34%	+191.73%	605B
JOHNSON & JOHNSON	+0.53%	+0.69%	+0.93%	-0.17%	398B
ABBVIE INC.	+0.10%	+0.42%	+28.48%	+80.69%	343B
MERCK & CO., INC.	+0.53%	-1.68%	+7.47%	+58.32%	294B
ROCHE HOLDING AG	+0.99%	-3.14%	+3.51%	-22.26%	252B
ASTRAZENECA PLC	-1.01%	-5.71%	+12.72%	+47.30%	243B
NOVARTIS AG	-0.28%	-0.45%	+9.29%	+24.89%	234B
AMGEN INC.	+0.72%	+3.71%	+29.24%	+53.40%	179B
Average	-0.13%	-0.28%	+20.25%	+80.23%	375.56B
Weighted average by Cap.	-0.08%	+0.61%	+26.87%	+124.75%

Employees

Sector